Michael Gwarisahttps://www.scidev.net/global/rss.xml/?type=author&rssname=michael-gwarisaMichael Gwarisa RSS feeds.Tue, 14 Jul 2026 04:49:54 GMTenDigital tools help Zimbabwe’s HIV migrants stay in carehttps://www.scidev.net/global/news/digital-tools-help-zimbabwes-hiv-migrants-stay-in-care/https://www.scidev.net/global/news/digital-tools-help-zimbabwes-hiv-migrants-stay-in-care/Zimbabwe is using telehealth and empathy-led care to reconnect deported migrants with HIV treatment. Mon, 13 Jul 2026 01:16:07 GMT+0000Michael Gwarisa‘Low risk’ as Africa hantavirus cases spur surveillancehttps://www.scidev.net/global/news/low-risk-as-africa-hantavirus-cases-spur-surveillance/https://www.scidev.net/global/news/low-risk-as-africa-hantavirus-cases-spur-surveillance/Potential and confirmed hantavirus cases in Zimbabwe and South Africa trigger heightened surveillance. Thu, 14 May 2026 02:28:20 GMT+0000Michael GwarisaZimbabwe’s new HIV drug at risk as US funding retreatshttps://www.scidev.net/global/features/zimbabwes-new-hiv-drug-at-risk-as-us-funding-retreats/https://www.scidev.net/global/features/zimbabwes-new-hiv-drug-at-risk-as-us-funding-retreats/US funding cuts cloud the future of Zimbabwe's lenacapavir rollout, raising fears of drug resistance. Fri, 3 Apr 2026 08:08:19 GMT+0000Michael Gwarisa